Compare PTGX & LW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PTGX | LW |
|---|---|---|
| Founded | 2006 | 1950 |
| Country | United States | United States |
| Employees | N/A | 10100 |
| Industry | Biotechnology: Pharmaceutical Preparations | Packaged Foods |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.4B | 5.9B |
| IPO Year | 2016 | 2016 |
| Metric | PTGX | LW |
|---|---|---|
| Price | $95.98 | $41.93 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 13 | 7 |
| Target Price | ★ $108.23 | $44.14 |
| AVG Volume (30 Days) | 455.9K | ★ 1.5M |
| Earning Date | 05-07-2026 | 04-01-2026 |
| Dividend Yield | N/A | ★ 3.53% |
| EPS Growth | N/A | ★ N/A |
| EPS | 0.05 | ★ 1.29 |
| Revenue | N/A | N/A |
| Revenue This Year | $874.25 | $4.26 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $1,898.40 | ★ $33.00 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $49.86 | $37.62 |
| 52 Week High | $107.84 | $67.07 |
| Indicator | PTGX | LW |
|---|---|---|
| Relative Strength Index (RSI) | 44.81 | 46.89 |
| Support Level | $96.36 | $40.25 |
| Resistance Level | $100.00 | $42.69 |
| Average True Range (ATR) | 3.91 | 1.46 |
| MACD | -0.55 | 0.00 |
| Stochastic Oscillator | 29.62 | 45.46 |
Protagonist Therapeutics Inc is a biopharmaceutical company engaged in the discovery and development of peptide-based therapeutics using its proprietary technology platform. The company focuses on three therapeutic areas: inflammation and immunology, hematology, and metabolic diseases. Its pipeline includes clinical-stage and preclinical candidates such as rusfertide for polycythemia vera, icotrokinra for inflammatory diseases, and other programs targeting IL-17, obesity, and iron metabolism disorders, developed through internal research and strategic collaborations.
Lamb Weston is North America's largest and the world's second-largest producer of branded and private-label frozen potato products, both by volume and value. The company's portfolio is anchored by french fries, but it also sells sweet potato fries, tater tots, diced potatoes, mashed potatoes, hash browns, and chips. Roughly two thirds of revenue comes from its home market of North America, with none of the other 100 countries the company sells into representing a significant share. McDonald's is Lamb Weston's single-largest customer at 15% of fiscal 2025 sales, with no other company representing more than 10%. Lamb Weston became an independent company in 2016 when it was spun off from Conagra.